TOI
The Oncology·NASDAQ
--
--(--)
--
--(--)
TOI fundamentals
The Oncology (TOI) released its earnings on Mar 12, 2026: revenue was 141.96M (YoY +41.58%), beat estimates; EPS was -0.06 (YoY +57.14%), beat estimates.
Revenue / YoY
141.96M
+41.58%
EPS / YoY
-0.06
+57.14%
Report date
Mar 12, 2026
TOI Earnings Call Summary for Q4,2025
- First Profitable Quarter: Achieved positive adjusted EBITDA in Q4 2025, marking a milestone for TOI as a public company.
- Revenue Growth: Full year 2025 revenue reached $502.7 million (+27.8% YoY), driven by capitated (+17.2%) and pharmacy (+49.6%) segments.
- Capitated Expansion: 2026 guidance includes $150 million in capitated revenue, with delegated model in Florida set to more than double.
- AI Efficiency: $2 million in SG&A savings expected from AI-driven prior auth, call center, and RCM optimizations.
- Free Cash Flow: Anticipated positivity in 2026H2, supported by Q4 2025 operating cash flow of $3.2 million.
- Market Positioning: Medicare Advantage rate cycle pressure is a strategic advantage, driving demand for TOI's cost-effective oncology care model.
Earnings
EPS
Revenue
Revenue & Expenses
TOI has released its 2025 Q4 earnings report, with revenue of 141.96M, reflecting a YoY change of 41.58%, and net profit of -7.51M, showing a YoY change of 43.04%. The Sankey diagram below clearly presents TOI's revenue sources and cost distribution.
Key Indicators
The Oncology (TOI) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
The Oncology (TOI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
The Oncology (TOI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
The Oncology (TOI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does The Oncology (TOI) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track The Oncology (TOI) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from The Oncology's earnings call?Did The Oncology beat or miss consensus estimates last quarter?What guidance did The Oncology's management provide for the next earnings period?What is The Oncology's gross profit margin?What is the market's earnings forecast for The Oncology next quarter?What is The Oncology's latest dividend and current dividend yield?What does The Oncology do and what are its main business segments?What is the revenue and EPS growth rate for The Oncology year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
